AGT and myalgic encephalomeyelitis/chronic fatigue syndrome: Treatment with miR-146a antagomiR inhibited the increases of collagen I and collagen III mRNA expression in CFs, but miR-146a agomiR exacerbated the increases of collagen I and collagen III expression induced by Ang II in CFs.